After approval by the FDA, AVT03 is expected to be supplied in a single-dose prefilled syringe containing 60 mg in a 1 ml solution, as well as a 120 mg/1.7 ml solution in a single-dose vial.

In an effort to guarantee "the ongoing quality, safety, nutritional adequacy, and resilience of the domestic infant formula ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

Creative Medical Technology Holdings announced that the U.S. Food and Drug Administration has cleared an expanded dose escalation for its ongoing Phase 1/2 trial of StemSpine usin ...

The U.S. Citizenship and Immigration Services (USCIS) has announced a new requirement for certain foreign nationals to ...

The FDA has approved Purified Cortrophin Gel (repository corticotropin injection USP) in a prefilled syringe presentation.

Dr. Reddy’s Laboratories RDY and partner, Alvotech ALVO, announced the FDA’s acceptance of a regulatory filing, seeking the ...

Acting Administrator Derek MaltzDrug Enforcement AdministrationATTN: DEA Federal Register Representative8701 Morrissette Dr.Springfield, VA 22152Re: Docket No. DEA-407 Special Registrationsfor Telemed ...

Despite a federal judge ordering deportation flights of Venezuelans to cease, video shows more deportees arriving in El ...